https://doi.org/10.1186/s12935-020-01738-2
Q
Qianwei Xing
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
48
Papers
718
Citations
17
h-index
24
i10-index
Qianwei Xing is an academic researcher from Nantong University. The author has contributed to research in topics: Ferroptosis and cancer prognosis & Renal cell carcinoma treatment & Cancer-related molecular mechanisms research. The author has an h-index of 17, co-authored 41 publications.
ORCID: 0000-0001-7466-908XPapers by this author
worksDecreased expression of METTL14 predicts poor prognosis and construction of a prognostic signature for clear cell renal cell carcinoma
2021 · Cancer Cell International · 31 citations
High expression of CDCA7 predicts poor prognosis for clear cell renal cell carcinoma and explores its associations with immunity
2021 · Cancer Cell International · 23 citations
https://doi.org/10.1186/s12935-021-01834-x
Prognostic value and immunological role of AXL gene in clear cell renal cell carcinoma associated with identifying LncRNA/RBP/AXL mRNA networks
2021 · Cancer Cell International · 19 citations
https://doi.org/10.1186/s12935-021-02322-y
Elevated CDC45 Expression Predicts Poorer Overall Survival Prognoses and Worse Immune Responses for Kidney Renal Clear Cell Carcinoma via Single-Cell and Bulk RNA-Sequencing
2023 · Biochemical Genetics · 5 citations
https://doi.org/10.1007/s10528-023-10500-y
Prostatitis, benign prostatic hyperplasia, and prostate cancer: a bidirectional Mendelian randomization study and clinical implications for these patients’ populations
2024 · Biology Direct · 1 citations
https://doi.org/10.1186/s13062-024-00575-x
The Negative Feedback of the Glutamine/Prostatitis Loop Identified Among 1400 Metabolites and Prostatitis via Mendelian Randomization
2025 · Mediators of Inflammation · 1 citations
https://doi.org/10.1155/mi/9648279
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat